YWP
GILD icon

YorkBridge Wealth Partners’s Gilead Sciences GILD Stock Holding History

YorkBridge Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-912
Closed -$71K – 746
2018
Q3 		$71K Hold
912
– – 0.03% 322
2018
Q2 		$65K Hold
912
– – 0.03% 338
2018
Q1 		$69K Sell
912
-170
-16% -$13.5K 0.03% 334
2017
Q4 		$85K Sell
1,082
-476
-31% -$36.1K 0.04% 312
2017
Q3 		$126K Sell
1,558
-1,225
-44% -$93.7K 0.07% 229
2017
Q2 		$197K Sell
2,783
-550
-17% -$36.6K 0.1% 174
2017
Q1 		$229K Buy
3,333
+198
+6% +$13.9K 0.12% 156
2016
Q4 		$237K Buy
+3,135
New +$233K 0.14% 139

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

YorkBridge Wealth Partners's GILD Position: Q4 2018 in Review

YorkBridge Wealth Partners sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 912 shares — an estimated $71K sold.

YorkBridge Wealth Partners first reported a position in GILD in Q4 2016 and held it in 8 quarters. The position peaked at $237K in Q4 2016. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • YorkBridge Wealth Partners reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 912 Gilead Sciences shares in Q4 2018, an estimated $71K.
  • YorkBridge Wealth Partners first reported a position in Gilead Sciences in Q4 2016 and held it in 8 quarters.
  • YorkBridge Wealth Partners's Gilead Sciences position peaked at $237K in Q4 2016.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2018, filed 14 Feb 2019.